title: Therapy for Parkinson's disease: what is in the pipeline?
abstract: Despite advances in the treatment of Parkinson's disease there are still many unmet needs, including neuroprotection, treatment of motor complications, treatment of dyskinesia, treatment of psychosis, and treatment of nondopaminergic symptoms. In this review, I highlight the obstacles to develop a neuroprotective drug and some of the treatment strategies recently approved or still in clinical trials designed to meet these unmet needs.
authors.affiliation: Institute for Research and Medical Care, IRCCS San Raffaele, Via della Pisana 235, 00163, Rome, Italy, fabrizio.stocchi@fastwebnet.it.
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Stocchi
mesh_terms: D000818:Animals; D015195:Drug Design; D055808:Drug Discovery; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*
chemical_list: D018696:Neuroprotective Agents